MCVIX
Price
$32.12
Change
+$0.12 (+0.38%)
Updated
Jul 16 closing price
Net Assets
16.82B
VMVIX
Price
$65.16
Change
+$0.31 (+0.48%)
Updated
Jul 16 closing price
Net Assets
30.57B
Interact to see
Advertisement

MCVIX vs VMVIX

Header iconMCVIX vs VMVIX Comparison
Open Charts MCVIX vs VMVIXBanner chart's image
MFS Mid Cap Value I
Price$32.12
Change+$0.12 (+0.38%)
VolumeN/A
Net Assets16.82B
Vanguard Mid-Cap Value Index Investor
Price$65.16
Change+$0.31 (+0.48%)
VolumeN/A
Net Assets30.57B
MCVIX vs VMVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MCVIX vs. VMVIX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCVIX is a Buy and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.6B vs. MCVIX (16.8B). VMVIX pays higher dividends than MCVIX: VMVIX (2.14) vs MCVIX (1.08). MCVIX was incepted earlier than VMVIX: MCVIX (24 years) vs VMVIX (19 years). MCVIX (0.75) is less costly to investors than VMVIX (0.19). MCVIX is a more actively managed with annual turnover of: 27.00 vs. VMVIX (19.00). MCVIX has a lower initial minimum investment than VMVIX: MCVIX (0) vs VMVIX (3000). VMVIX annual gain was more profitable for investors over the last year : 4.51 vs. MCVIX (-5.68). VMVIX return over 5 years is better than : 66.84 vs. MCVIX (53.26).
MCVIXVMVIXMCVIX / VMVIX
Total Expense Ratio0.740.19389%
Annual Report Gross Expense Ratio0.750.19395%
Fund Existence24 years19 years-
Gain YTD0.8191.89343%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets16.8B30.6B55%
Annual Yield % from dividends1.082.1451%
Returns for 1 year-5.684.51-126%
Returns for 3 years18.4526.9868%
Returns for 5 years53.2666.8480%
Returns for 10 years64.5684.0177%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INBX23.650.69
+3.01%
Inhibrx Biosciences Inc.
ALGS8.680.18
+2.12%
Aligos Therapeutics Inc
OCSL14.610.16
+1.11%
Oaktree Specialty Lending Corp
WTFCM25.00N/A
N/A
Wintrust Financial Corp
CMA61.14-0.09
-0.15%
Comerica